Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -7.77M | -152.23% | $ 5.1M |
3/31/2025 | $ -7.02M | -254.96% | $ 2.75M |
12/31/2024 | $ -7.29M | -188.78% | $ 3.86M |
9/30/2024 | $ -6.65M | -182.25% | $ 3.65M |
6/30/2024 | $ -7M | -221.25% | $ 3.16M |
3/31/2024 | $ -6.66M | -298.33% | $ 2.23M |
12/31/2023 | $ -6.51M | -301.99% | $ 2.16M |
9/30/2023 | $ -7.36M | -363.03% | $ 2.03M |
6/30/2023 | $ -7.45M | -319.61% | $ 2.33M |
3/31/2023 | $ -10.8M | -279.76% | $ 3.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for INMED PHARMACEUTICALS INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 20.83M ]
(=) FCF Yield [ 0% ]
Minimum
Sep 30, 2022
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |